CASP3 and cancer: Immunohistochemical staining of cleaved Caspase 3 in tumor sections revealed that cancer cell apoptosis was increased by Sorafenib treatment but was even higher upon combination of Sorafenib with depletion of USP29 (Fig. 6d, e).